UK markets close in 8 hours 2 minutes

IDEAYA Biosciences, Inc. (30J.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
37.60+0.40 (+1.09%)
As of 08:03AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.89B
Enterprise value 2.24B
Trailing P/E N/A
Forward P/E 9.49
PEG ratio (5-yr expected) N/A
Price/sales (ttm)166.06
Price/book (mrq)3.25
Enterprise value/revenue 5.53
Enterprise value/EBITDA -4.66

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 386.00%
S&P500 52-week change 326.27%
52-week high 344.40
52-week low 318.90
50-day moving average 338.76
200-day moving average 331.89

Share statistics

Avg vol (3-month) 319
Avg vol (10-day) 3N/A
Shares outstanding 575.69M
Implied shares outstanding 677.7M
Float 874.84M
% held by insiders 11.11%
% held by institutions 1106.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,026.55%

Management effectiveness

Return on assets (ttm)-15.00%
Return on equity (ttm)-20.31%

Income statement

Revenue (ttm)15.51M
Revenue per share (ttm)0.24
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -156.66M
Net income avi to common (ttm)-128.89M
Diluted EPS (ttm)-1.86
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)698.77M
Total cash per share (mrq)9.23
Total debt (mrq)2.41M
Total debt/equity (mrq)0.26%
Current ratio (mrq)28.42
Book value per share (mrq)12.51

Cash flow statement

Operating cash flow (ttm)-131.19M
Levered free cash flow (ttm)-88.05M